GeneDx Holdings WGS Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Business | ||||||
| GeneDx | $101.5M+16.5% | $119.49M+25.4% | $114.7M+49.7% | $101.78M+47.7% | $87.12M+41.7% | |
| Other | $758K— | —— | —— | —— | $0-100% | |
| Adjusted Gross Margin by Business | ||||||
| GeneDx | $69.88M+17.0% | $85M+27.0% | $84.45M+71.5% | $71.82M+69.4% | $59.72M+59.8% | |
| Other | $170K— | —— | —— | —— | $0-100% | |
| Adjusted cost of services by Business | ||||||
| GeneDx | $31.61M+15.4% | $34.49M+21.5% | $30.25M+10.5% | $29.96M+13.0% | $27.4M+13.7% | |
| Other | $588K— | —— | —— | —— | $0-100% | |
| Total Revenue by Product | ||||||
| Institutional customers | $16.09M-8.6% | $15.94M+11.2% | $17.87M+2.6% | $18.38M+10.1% | $17.6M+5.6% | |
| Patients with third-party insurance | $84.92M+24.8% | $101.05M+27.5% | $95.02M+59.6% | $81.1M+55.8% | $68.06M+55.2% | |
| Self-pay patients | $286K+198% | $297K-50.5% | $629K+36.7% | $339K-51.0% | $96K-83.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does GeneDx Holdings break its business down?
- GeneDx Holdings (WGS) reports total revenue by business across 2 parts — GeneDx and Other. Each is extracted from the segment footnotes and tracked over time.
- Where does GeneDx Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in GeneDx Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.